BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 38408048)

  • 1. Detection of driver mutations and genomic signatures in endometrial cancers using artificial intelligence algorithms.
    Stan A; Bosart K; Kaur M; Vo M; Escorcia W; Yoder RJ; Bouley RA; Petreaca RC
    PLoS One; 2024; 19(2):e0299114. PubMed ID: 38408048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic Analysis of Uterine Lavage Fluid Detects Early Endometrial Cancers and Reveals a Prevalent Landscape of Driver Mutations in Women without Histopathologic Evidence of Cancer: A Prospective Cross-Sectional Study.
    Nair N; Camacho-Vanegas O; Rykunov D; Dashkoff M; Camacho SC; Schumacher CA; Irish JC; Harkins TT; Freeman E; Garcia I; Pereira E; Kendall S; Belfer R; Kalir T; Sebra R; Reva B; Dottino P; Martignetti JA
    PLoS Med; 2016 Dec; 13(12):e1002206. PubMed ID: 28027320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of a custom designed next generation DNA sequencing gene panel to molecularly classify endometrial cancers according to The Cancer Genome Atlas subgroups.
    Miller EM; Patterson NE; Gressel GM; Karabakhtsian RG; Bejerano-Sagie M; Ravi N; Maslov A; Quispe-Tintaya W; Wang T; Lin J; Smith HO; Goldberg GL; Kuo DYS; Montagna C
    BMC Med Genomics; 2020 Nov; 13(1):179. PubMed ID: 33256706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinguishing between driver and passenger mutations in individual cancer genomes by network enrichment analysis.
    Merid SK; Goranskaya D; Alexeyenko A
    BMC Bioinformatics; 2014 Sep; 15(1):308. PubMed ID: 25236784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interpretation of somatic POLE mutations in endometrial carcinoma.
    León-Castillo A; Britton H; McConechy MK; McAlpine JN; Nout R; Kommoss S; Brucker SY; Carlson JW; Epstein E; Rau TT; Bosse T; Church DN; Gilks CB
    J Pathol; 2020 Mar; 250(3):323-335. PubMed ID: 31829442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel mutations in endometrial cancer patients by whole-exome sequencing.
    Chang YS; Huang HD; Yeh KT; Chang JG
    Int J Oncol; 2017 May; 50(5):1778-1784. PubMed ID: 28339086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational analysis of the tyrosine kinome in serous and clear cell endometrial cancer uncovers rare somatic mutations in TNK2 and DDR1.
    Rudd ML; Mohamed H; Price JC; O'Hara AJ; Le Gallo M; Urick ME; ; Cruz P; Zhang S; Hansen NF; Godwin AK; Sgroi DC; Wolfsberg TG; Mullikin JC; Merino MJ; Bell DW
    BMC Cancer; 2014 Nov; 14():884. PubMed ID: 25427824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic POLE exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neoantigen burden and immune response.
    Temko D; Van Gool IC; Rayner E; Glaire M; Makino S; Brown M; Chegwidden L; Palles C; Depreeuw J; Beggs A; Stathopoulou C; Mason J; Baker AM; Williams M; Cerundolo V; Rei M; Taylor JC; Schuh A; Ahmed A; Amant F; Lambrechts D; Smit VT; Bosse T; Graham TA; Church DN; Tomlinson I
    J Pathol; 2018 Jul; 245(3):283-296. PubMed ID: 29604063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide mutation analysis in precancerous lesions of endometrial carcinoma.
    Li L; Yue P; Song Q; Yen TT; Asaka S; Wang TL; Beavis AL; Fader AN; Jiao Y; Yuan G; Shih IM; Song Y
    J Pathol; 2021 Jan; 253(1):119-128. PubMed ID: 33016334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer.
    Liang H; Cheung LW; Li J; Ju Z; Yu S; Stemke-Hale K; Dogruluk T; Lu Y; Liu X; Gu C; Guo W; Scherer SE; Carter H; Westin SN; Dyer MD; Verhaak RG; Zhang F; Karchin R; Liu CG; Lu KH; Broaddus RR; Scott KL; Hennessy BT; Mills GB
    Genome Res; 2012 Nov; 22(11):2120-9. PubMed ID: 23028188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression.
    Ashley CW; Da Cruz Paula A; Kumar R; Mandelker D; Pei X; Riaz N; Reis-Filho JS; Weigelt B
    Gynecol Oncol; 2019 Jan; 152(1):11-19. PubMed ID: 30415991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial polyps are non-neoplastic but harbor epithelial mutations in endometrial cancer drivers at low allelic frequencies.
    Sahoo SS; Aguilar M; Xu Y; Lucas E; Miller V; Chen H; Zheng W; Cuevas IC; Li HD; Hitrys D; Wachsmann MB; Bishop JA; Cantarell B; Gagan J; Koduru P; SoRelle JA; Castrillon DH
    Mod Pathol; 2022 Nov; 35(11):1702-1712. PubMed ID: 35798968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequencing of candidate chromosome instability genes in endometrial cancers reveals somatic mutations in ESCO1, CHTF18, and MRE11A.
    Price JC; Pollock LM; Rudd ML; Fogoros SK; Mohamed H; Hanigan CL; Le Gallo M; ; Zhang S; Cruz P; Cherukuri PF; Hansen NF; McManus KJ; Godwin AK; Sgroi DC; Mullikin JC; Merino MJ; Hieter P; Bell DW
    PLoS One; 2014; 8(6):e63313. PubMed ID: 23755103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensively Exploring the Mutational Landscape and Patterns of Genomic Evolution in Hypermutated Cancers.
    Lin PC; Yeh YM; Hsu HP; Chan RH; Lin BW; Chen PC; Pan CC; Hsu KF; Hsiao JR; Shan YS; Shen MR
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein Arginine Methyltransferase 5 (PRMT5) Mutations in Cancer Cells.
    Rasheed S; Bouley RA; Yoder RJ; Petreaca RC
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic mutations in histologically normal endometrium: the new normal?
    Lac V; Nazeran TM; Tessier-Cloutier B; Aguirre-Hernandez R; Albert A; Lum A; Khattra J; Praetorius T; Mason M; Chiu D; Köbel M; Yong PJ; Gilks BC; Anglesio MS; Huntsman DG
    J Pathol; 2019 Oct; 249(2):173-181. PubMed ID: 31187483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational signatures for breast cancer diagnosis using artificial intelligence.
    Odhiambo P; Okello H; Wakaanya A; Wekesa C; Okoth P
    J Egypt Natl Canc Inst; 2023 May; 35(1):14. PubMed ID: 37184779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-canonical genomic driver mutations of urethane carcinogenesis.
    Li S; Counter CM
    PLoS One; 2022; 17(4):e0267147. PubMed ID: 35482806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passenger Mutations in More Than 2,500 Cancer Genomes: Overall Molecular Functional Impact and Consequences.
    Kumar S; Warrell J; Li S; McGillivray PD; Meyerson W; Salichos L; Harmanci A; Martinez-Fundichely A; Chan CWY; Nielsen MM; Lochovsky L; Zhang Y; Li X; Lou S; Pedersen JS; Herrmann C; Getz G; Khurana E; Gerstein MB
    Cell; 2020 Mar; 180(5):915-927.e16. PubMed ID: 32084333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer.
    Shi MJ; Meng XY; Fontugne J; Chen CL; Radvanyi F; Bernard-Pierrot I
    Genome Med; 2020 Sep; 12(1):85. PubMed ID: 32988402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.